Examine the evolution of SkinHealth Systems Inc.'s (SKIN) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Beauty Health (NASDAQ:SKIN) reported second-quarter revenue at the low end of its guidance range as cautious capital spending by providers continued to weigh on equipment sales, while stronger gross margins and expense discipline lifted adjusted EBITDA above expectations. SkinHealth Systems Inc., w

Moby summary of The Beauty Health Company's Q2 2026 earnings call

Adjusted EBITDA surged past guidance with record margins, while the company navigates softer sales and a NASDAQ compliance challenge.

Although the revenue and EPS for SkinHealth Systems Inc. (SKIN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

SkinHealth Systems Inc. (SKIN) delivered earnings and revenue surprises of +50.00% and -1.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

SkinHealth Systems Inc. (SKIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SkinHealth Systems Inc. (SKIN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).